Universal Starch Chem Allied (BSE 524408)₹199.15−1.36%Other Agricultural Products
In the Mar 2026 quarter (standalone), Universal Starch Chem Allied reported sales of ₹152 Cr, up 10.2% from Mar 2025, and net profit of ₹9.59 Cr, up 227.3% year on year. For the year to Mar 2026, sales were ₹489 Cr and net profit ₹12.95 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 136 | 120 | 126 | 145 | 133 | 90.97 | 129 | 138 | 121 | 97.09 | 118 | 152 |
| Expenses | 129 | 116 | 124 | 138 | 128 | 96.11 | 118 | 131 | 120 | 92.59 | 108 | 136 |
| Operating Profit | 6.68 | 4.08 | 1.93 | 7.39 | 5.37 | −5.19 | 10.48 | 7.69 | 1.57 | 4.53 | 9.76 | 16.35 |
| OPM % | 4.9% | 3.4% | 1.5% | 5.1% | 4.0% | −5.7% | 8.1% | 5.6% | 1.3% | 4.7% | 8.3% | 10.7% |
| Other Income | 0.31 | 0.57 | 0.31 | 1.94 | 0.35 | 0.40 | 0.21 | 0.57 | 0.19 | 0.52 | 0.29 | 0.52 |
| Interest | 1.76 | 2.18 | 2.13 | 2.09 | 2.23 | 2.35 | 2.04 | 2.64 | 2.37 | 2.37 | 1.74 | 1.63 |
| Depreciation | 1.38 | 1.42 | 1.49 | 1.46 | 1.47 | 1.52 | 1.56 | 1.69 | 1.84 | 1.85 | 1.85 | 1.80 |
| Profit before tax | 3.82 | 1.02 | −1.39 | 5.74 | 1.99 | −8.67 | 7.04 | 3.90 | −2.46 | 0.80 | 6.42 | 13.38 |
| Tax % | −12.0% | 26.2% | −29.3% | 22.2% | 27.0% | −5.7% | 0.7% | 24.8% | 1.2% | 6.2% | 18.8% | 28.3% |
| Net Profit | 4.28 | 0.75 | −0.97 | 4.46 | 1.45 | −8.20 | 7.00 | 2.93 | −2.50 | 0.75 | 5.23 | 9.59 |
| EPS (Rs) | 10.19 | 1.80 | −2.32 | 10.65 | 3.47 | −19.54 | 16.68 | 6.99 | −5.97 | 1.80 | 12.45 | 22.91 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 165 | 214 | 198 | 279 | 264 | 296 | 456 | 516 | 527 | 491 | 489 | 489 |
| Expenses | 163 | 215 | 190 | 267 | 254 | 279 | 431 | 498 | 507 | 473 | 456 | 456 |
| Operating Profit | 1.99 | −0.99 | 7.99 | 11.99 | 9.99 | 17.99 | 25.98 | 16.98 | 19.98 | 17.99 | 31.95 | 32.21 |
| OPM % | 1.3% | −0.3% | 3.8% | 4.1% | 3.8% | 6.0% | 6.0% | 3.4% | 3.8% | 3.7% | 7.0% | 6.6% |
| Other Income | 3.01 | 3.01 | 1.01 | 2.01 | 2.01 | 1.01 | 2.01 | 3.01 | 3.01 | 2.01 | 1.01 | 1.52 |
| Interest | 3.98 | 3.99 | 3.99 | 5.98 | 6.98 | 6.98 | 7.97 | 6.98 | 7.97 | 8.98 | 7.98 | 8.11 |
| Depreciation | 3.99 | 3.99 | 3.99 | 3.99 | 4.99 | 3.99 | 3.99 | 4.98 | 5.98 | 5.98 | 6.98 | 7.34 |
| Profit before tax | −3.99 | −5.98 | 0.99 | 2.99 | 0.00 | 6.97 | 15.94 | 7.97 | 8.96 | 3.99 | 17.93 | 18.14 |
| Tax % | −55.0% | −29.0% | 73.0% | 54.0% | −61.0% | 12.0% | 28.0% | 27.0% | 24.0% | 25.0% | 28.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | −1.99 | −3.98 | 0.00 | 0.99 | 0.99 | 5.98 | 10.96 | 5.98 | 6.97 | 2.99 | 12.95 | 13.07 |
| EPS (Rs) | −4.01 | −10.03 | 0.59 | 3.37 | 1.56 | 15.13 | 27.18 | 14.02 | 16.61 | 7.63 | 31.21 | 31.19 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.01 | 4.01 | 4.01 | 4.01 | 4.01 | 4.01 | 4.01 | 4.01 | 4.01 | 4.01 | 4.01 | 4.01 |
| Reserves | 5.99 | 3.99 | 8.97 | 8.97 | 31.92 | 33.94 | 36.92 | 47.90 | 53.91 | 61.84 | 65.89 | 77.82 |
| Borrowings | 30.91 | 35.88 | 28.92 | 43.85 | 55.86 | 46.87 | 63.83 | 49.85 | 72.81 | 71.80 | 78.73 | 53.86 |
| Other Liabilities | 47.97 | 48.98 | 62.94 | 46.93 | 55.88 | 71.82 | 71.02 | 84.92 | 73.88 | 84.97 | 75.91 | 77.80 |
| Total Liabilities | 89.88 | 93.86 | 106 | 104 | 149 | 157 | 175 | 187 | 204 | 224 | 226 | 213 |
| Fixed Assets | 43.86 | 43.85 | 52.85 | 49.79 | 87.69 | 83.65 | 85.76 | 96.70 | 102 | 103 | 121 | 116 |
| CWIP | 3.01 | 0.00 | 0.00 | 1.01 | 1.01 | 1.01 | 3.01 | 6.02 | 5.01 | 7.02 | 1.01 | 1.01 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 43.01 | 50.01 | 51.99 | 53.96 | 59.97 | 71.98 | 86.01 | 82.96 | 97.02 | 114 | 103 | 96.95 |
| Inventories | 10.96 | 18.93 | 16.93 | 14.94 | 19.93 | 28.89 | 31.87 | 21.92 | 31.88 | 37.88 | 34.85 | 25.89 |
| Trade receivables | 18.07 | 20.06 | 21.10 | 25.09 | 26.09 | 30.13 | 35.12 | 46.17 | 46.20 | 53.24 | 46.19 | 57.22 |
| Cash & equivalents | 5.99 | 2.99 | 2.01 | 2.01 | 5.01 | 3.01 | 6.01 | 3.99 | 8.01 | 6.99 | 7.01 | 4.99 |
| Total Assets | 89.88 | 93.86 | 106 | 104 | 149 | 157 | 175 | 187 | 204 | 224 | 226 | 213 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 17.01 | −4.01 | 13.01 | −8.01 | 11.01 | 11.01 | 11.02 | 34.04 | −1.01 | 19.04 | 23.02 | 17.01 |
| Cash from investing activity | −5.01 | −2.01 | −2.01 | −0.99 | −18.01 | −1.01 | −8.99 | −18.01 | −8.99 | −9.01 | −18.01 | −1.99 |
| Cash from financing activity | −8.97 | 2.99 | −10.97 | 7.98 | 9.96 | −10.97 | 0.99 | −17.95 | 13.97 | −9.97 | −4.99 | −16.95 |
| Net cash flow | 3.01 | −3.01 | 0.00 | 0.00 | 2.01 | −0.99 | 3.01 | −1.99 | 4.01 | 0.00 | 0.00 | −1.99 |
| Capex | 4.80 | 1.74 | 2.33 | 1.04 | 19.55 | 0.99 | 8.28 | 18.55 | 8.57 | 8.83 | 18.51 | 1.97 |
| Free cash flow | 11.99 | −5.99 | 10.99 | −8.99 | −7.99 | 9.99 | 1.99 | 15.99 | −8.99 | 9.99 | 3.99 | 14.99 |
| CFO / OP % | 284.9% | −190.1% | −1,976.1% | −100.1% | 99.0% | 110.9% | 65.9% | 141.9% | 6.0% | 96.9% | 123.0% | 60.9% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 34 | 44 | 36 | 47 | 34 | 42 | 43 | 37 | 32 | 37 | 35 | 43 |
| Inventory days | 23 | 49 | 36 | 33 | 37 | 53 | 60 | 26 | 32 | 36 | 35 | 25 |
| Days payable | 78 | 102 | 120 | 83 | 71 | 105 | 95 | 74 | 52 | 62 | 55 | 37 |
| Cash conversion cycle | −18 | −8 | −46 | −2 | 2 | −8 | 11 | −10 | 15 | 13 | 17 | 32 |
| Working capital days | −26 | −32 | −42 | −15 | −24 | −20 | −2 | −3 | −9 | −8 | −16 | −1 |
| ROCE % | 7.0% | 1.0% | −5.0% | 9.0% | 11.9% | 8.0% | 15.0% | 23.0% | 13.0% | 13.0% | 9.0% | 18.0% |
For the Mar 2026 quarter, Universal Starch Chem Allied reported sales of ₹152 Cr, up 10.2% year on year and net profit of ₹9.59 Cr, up 227.3% year on year. The operating margin was 10.7%.
Universal Starch Chem Allied's sales for the year to Mar 2026 were ₹489 Cr; over the last twelve months they were ₹489 Cr.
Net profit for the year to Mar 2026 was ₹12.95 Cr, and ₹13.07 Cr over the last twelve months. Earnings per share over the same trailing period were ₹31.19.
Universal Starch Chem Allied reported borrowings of ₹53.86 Cr at Mar 2026, against cash and equivalents of ₹4.99 Cr.
Cash from operations was ₹17.01 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹14.99 Cr.